Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochim Biophys Acta ; 1841(7): 970-6, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24681165

RESUMEN

Lipoprotein lipase (LPL) has been highly conserved through vertebrate evolution, making it challenging to generate useful antibodies. Some polyclonal antibodies against LPL have turned out to be nonspecific, and the available monoclonal antibodies (Mabs) against LPL, all of which bind to LPL's carboxyl terminus, have drawbacks for some purposes. We report a new LPL-specific monoclonal antibody, Mab 4-1a, which binds to the amino terminus of LPL (residues 5-25). Mab 4-1a binds human and bovine LPL avidly; it does not inhibit LPL catalytic activity nor does it interfere with the binding of LPL to heparin. Mab 4-1a does not bind to human hepatic lipase. Mab 4-1a binds to GPIHBP1-bound LPL and does not interfere with the ability of the LPL-GPIHBP1 complex to bind triglyceride-rich lipoproteins. Mab 4-1a will be a useful reagent for both biochemists and clinical laboratories.


Asunto(s)
Anticuerpos Monoclonales/metabolismo , Lipoproteína Lipasa/metabolismo , Receptores de Lipoproteína/metabolismo , Triglicéridos/metabolismo , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/biosíntesis , Anticuerpos Monoclonales/aislamiento & purificación , Afinidad de Anticuerpos , Especificidad de Anticuerpos , Células CHO , Bovinos , Cricetulus , Expresión Génica , Heparina/metabolismo , Humanos , Lipasa/metabolismo , Lipoproteína Lipasa/genética , Ratones , Datos de Secuencia Molecular , Unión Proteica , Estructura Terciaria de Proteína , Transporte de Proteínas , Receptores de Lipoproteína/genética , Transfección
2.
Biochim Biophys Acta ; 1841(7): 963-9, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24704550

RESUMEN

The S447X polymorphism in lipoprotein lipase (LPL), which shortens LPL by two amino acids, is associated with low plasma triglyceride levels and reduced risk for coronary heart disease. S447X carriers have higher LPL levels in the pre- and post-heparin plasma, raising the possibility that the S447X polymorphism leads to higher LPL levels within capillaries. One potential explanation for increased amounts of LPL in capillaries would be more avid binding of S447X-LPL to GPIHBP1 (the protein that binds LPL dimers and shuttles them to the capillary lumen). This explanation seems plausible because sequences within the carboxyl terminus of LPL are known to mediate LPL binding to GPIHBP1. To assess the impact of the S447X polymorphism on LPL binding to GPIHBP1, we compared the ability of internally tagged versions of wild-type LPL (WT-LPL) and S447X-LPL to bind to GPIHBP1 in both cell-based and cell-free binding assays. In the cell-based assay, we compared the binding of WT-LPL and S447X-LPL to GPIHBP1 on the surface of cultured cells. This assay revealed no differences in the binding of WT-LPL and S447X-LPL to GPIHBP1. In the cell-free assay, we compared the binding of internally tagged WT-LPL and S447X-LPL to soluble GPIHBP1 immobilized on agarose beads. Again, no differences in the binding of WT-LPL and S447X-LPL to GPIHBP1 were observed. We conclude that increased binding of S447X-LPL to GPIHBP1 is unlikely to be the explanation for more efficient lipolysis and lower plasma triglyceride levels in S447X carriers.


Asunto(s)
Proteínas Inmovilizadas/metabolismo , Lipoproteína Lipasa/metabolismo , Polimorfismo de Nucleótido Simple , Receptores de Lipoproteína/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Triglicéridos/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Bioensayo , Células CHO , Cricetulus , Expresión Génica , Humanos , Proteínas Inmovilizadas/genética , Metabolismo de los Lípidos , Lipoproteína Lipasa/genética , Datos de Secuencia Molecular , Unión Proteica , Transporte de Proteínas , Receptores de Lipoproteína/genética , Proteínas Recombinantes de Fusión/genética
3.
Cell Metab ; 19(5): 849-60, 2014 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-24726386

RESUMEN

Triglyceride-rich lipoproteins (TRLs) undergo lipolysis by lipoprotein lipase (LPL), an enzyme that is transported to the capillary lumen by an endothelial cell protein, GPIHBP1. For LPL-mediated lipolysis to occur, TRLs must bind to the lumen of capillaries. This process is often assumed to involve heparan sulfate proteoglycans (HSPGs), but we suspected that TRL margination might instead require GPIHBP1. Indeed, TRLs marginate along the heart capillaries of wild-type but not Gpihbp1⁻/⁻ mice, as judged by fluorescence microscopy, quantitative assays with infrared-dye-labeled lipoproteins, and EM tomography. Both cell-culture and in vivo studies showed that TRL margination depends on LPL bound to GPIHBP1. Notably, the expression of LPL by endothelial cells in Gpihbp1⁻/⁻ mice did not restore defective TRL margination, implying that the binding of LPL to HSPGs is ineffective in promoting TRL margination. Our studies show that GPIHBP1-bound LPL is the main determinant of TRL margination.


Asunto(s)
Capilares/metabolismo , Lipoproteína Lipasa/metabolismo , Lipoproteínas/metabolismo , Receptores de Lipoproteína/metabolismo , Triglicéridos/metabolismo , Animales , Línea Celular , Células Endoteliales/metabolismo , Corazón/fisiología , Ratones
4.
J Lipid Res ; 53(12): 2690-7, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23008484

RESUMEN

Lipoprotein lipase (LPL) is secreted into the interstitial spaces by adipocytes and myocytes but then must be transported to the capillary lumen by GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells. The mechanism by which GPIHBP1 and LPL move across endothelial cells remains unclear. We asked whether the transport of GPIHBP1 and LPL across endothelial cells was uni- or bidirectional. We also asked whether GPIHBP1 and LPL are transported across cells in vesicles and whether this transport process requires caveolin-1. The movement of GPIHBP1 and LPL across cultured endothelial cells was bidirectional. Also, GPIHBP1 moved bidirectionally across capillary endothelial cells in live mice. The transport of LPL across endothelial cells was inhibited by dynasore and genistein, consistent with a vesicular transport process. Also, transmission electron microscopy (EM) and dual-axis EM tomography revealed GPIHBP1 and LPL in invaginations of the plasma membrane and in vesicles. The movement of GPIHBP1 across capillary endothelial cells was efficient in the absence of caveolin-1, and there was no defect in the internalization of LPL by caveolin-1-deficient endothelial cells in culture. Our studies show that GPIHBP1 and LPL move bidirectionally across endothelial cells in vesicles and that transport is efficient even when caveolin-1 is absent.


Asunto(s)
Células Endoteliales/metabolismo , Lipoproteína Lipasa/metabolismo , Receptores de Lipoproteína/metabolismo , Animales , Células CHO , Cricetinae , Células Endoteliales/química , Células Endoteliales/enzimología , Genisteína/farmacología , Humanos , Hidrazonas/farmacología , Lipoproteína Lipasa/antagonistas & inhibidores , Ratones , Ratones Noqueados , Ratas , Receptores de Lipoproteína/deficiencia , Relación Estructura-Actividad
5.
Hum Mol Genet ; 21(13): 2961-72, 2012 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-22493000

RESUMEN

Lipoprotein lipase (LPL) is a 448-amino-acid head-to-tail dimeric enzyme that hydrolyzes triglycerides within capillaries. LPL is secreted by parenchymal cells into the interstitial spaces; it then binds to GPIHBP1 (glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1) on the basolateral face of endothelial cells and is transported to the capillary lumen. A pair of amino acid substitutions, C418Y and E421K, abolish LPL binding to GPIHBP1, suggesting that the C-terminal portion of LPL is important for GPIHBP1 binding. However, a role for LPL's N terminus has not been excluded, and published evidence has suggested that only full-length homodimers are capable of binding GPIHBP1. Here, we show that LPL's C-terminal domain is sufficient for GPIHBP1 binding. We found, serendipitously, that two LPL missense mutations, G409R and E410V, render LPL susceptible to cleavage at residue 297 (a known furin cleavage site). The C terminus of these mutants (residues 298-448), bound to GPIHBP1 avidly, independent of the N-terminal fragment. We also generated an LPL construct with an in-frame deletion of the N-terminal catalytic domain (residues 50-289); this mutant was secreted but also was cleaved at residue 297. Once again, the C-terminal domain (residues 298-448) bound GPIHBP1 avidly. The binding of the C-terminal fragment to GPIHBP1 was eliminated by C418Y or E421K mutations. After exposure to denaturing conditions, the C-terminal fragment of LPL refolds and binds GPIHBP1 avidly. Thus, the binding of LPL to GPIHBP1 requires only the C-terminal portion of LPL and does not depend on full-length LPL homodimers.


Asunto(s)
Proteínas Portadoras/metabolismo , Lipoproteína Lipasa/metabolismo , Sustitución de Aminoácidos , Animales , Células CHO , Proteínas Portadoras/genética , Quilomicrones/sangre , Cricetinae , Células Endoteliales/metabolismo , Furina/metabolismo , Lipoproteína Lipasa/química , Lipoproteína Lipasa/genética , Mutación Missense , Péptidos/genética , Péptidos/metabolismo , Unión Proteica
6.
Phys Rev Lett ; 109(26): 265501, 2012 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-23368578

RESUMEN

We report the chain conformations of polymer molecules accommodated at the solid-polymer melt interfaces in equilibrium. Polystyrene "Guiselin" brushes (adsorbed layers) with different molecular weights were prepared on Si substrates and characterized by using x-ray and neutron reflectivity. The results are intriguing to show that the adsorbed layers are composed of the two different nanoarchitectures: flattened chains that constitute the inner higher density region of the adsorbed layers and loosely adsorbed polymer chains that form the outer bulklike density region. In addition, we found that the lone flattened chains, which are uncovered by the additional prolonged solvent leaching (∼120 days), are reversibly densified with increasing temperature up to 150 °C. By generalizing the chain conformations of bulks, we postulate that the change in probabilities of the local chain conformations (i.e., trans and gauche states) of polymer molecules is the origin of this densification process.


Asunto(s)
Nanoestructuras/química , Poliestirenos/química , Silicio/química , Adsorción , Cinética , Modelos Químicos , Conformación Molecular , Propiedades de Superficie , Temperatura de Transición
7.
J Lipid Res ; 52(11): 1869-84, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21844202

RESUMEN

Interest in lipolysis and the metabolism of triglyceride-rich lipoproteins was recently reignited by the discovery of severe hypertriglyceridemia (chylomicronemia) in glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1)-deficient mice. GPIHBP1 is expressed exclusively in capillary endothelial cells and binds lipoprotein lipase (LPL) avidly. These findings prompted speculation that GPIHBP1 serves as a binding site for LPL in the capillary lumen, creating "a platform for lipolysis." More recent studies have identified a second and more intriguing role for GPIHBP1-picking up LPL in the subendothelial spaces and transporting it across endothelial cells to the capillary lumen. Here, we review the studies that revealed that GPIHBP1 is the LPL transporter and discuss which amino acid sequences are required for GPIHBP1-LPL interactions. We also discuss the human genetics of LPL transport, focusing on cases of chylomicronemia caused by GPIHBP1 mutations that abolish GPIHBP1's ability to bind LPL, and LPL mutations that prevent LPL binding to GPIHBP1.


Asunto(s)
Proteínas Portadoras/metabolismo , Células Endoteliales/metabolismo , Lipoproteína Lipasa/metabolismo , Secuencia de Aminoácidos , Animales , Células CHO , Proteínas Portadoras/química , Proteínas Portadoras/genética , Cricetinae , Cricetulus , Humanos , Datos de Secuencia Molecular , Transporte de Proteínas , Receptores de Lipoproteína
8.
Proc Natl Acad Sci U S A ; 108(19): 7980-4, 2011 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-21518912

RESUMEN

GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells, shuttles lipoprotein lipase (LPL) from subendothelial spaces to the capillary lumen. An absence of GPIHBP1 prevents the entry of LPL into capillaries, blocking LPL-mediated triglyceride hydrolysis and leading to markedly elevated triglyceride levels in the plasma (i.e., chylomicronemia). Earlier studies have established that chylomicronemia can be caused by LPL mutations that interfere with catalytic activity. We hypothesized that some cases of chylomicronemia might be caused by LPL mutations that interfere with LPL's ability to bind to GPIHBP1. Any such mutation would provide insights into LPL sequences required for GPIHBP1 binding. Here, we report that two LPL missense mutations initially identified in patients with chylomicronemia, C418Y and E421K, abolish LPL's ability to bind to GPIHBP1 without interfering with LPL catalytic activity or binding to heparin. Both mutations abolish LPL transport across endothelial cells by GPIHBP1. These findings suggest that sequences downstream from LPL's principal heparin-binding domain (amino acids 403-407) are important for GPIHBP1 binding. In support of this idea, a chicken LPL (cLPL)-specific monoclonal antibody, xCAL 1-11 (epitope, cLPL amino acids 416-435), blocks cLPL binding to GPIHBP1 but not to heparin. Also, changing cLPL residues 421 to 425, 426 to 430, and 431 to 435 to alanine blocks cLPL binding to GPIHBP1 without inhibiting catalytic activity. Together, these data define a mechanism by which LPL mutations could elicit disease and provide insights into LPL sequences required for binding to GPIHBP1.


Asunto(s)
Proteínas Portadoras/metabolismo , Células Endoteliales/metabolismo , Lipoproteína Lipasa/genética , Lipoproteína Lipasa/metabolismo , Mutación Missense , Sustitución de Aminoácidos , Animales , Sitios de Unión/genética , Células CHO , Quilomicrones/sangre , Quilomicrones/genética , Cricetinae , Cricetulus , Humanos , Hiperlipoproteinemia Tipo IV/sangre , Hiperlipoproteinemia Tipo IV/enzimología , Hiperlipoproteinemia Tipo IV/genética , Proteínas Mutantes/genética , Proteínas Mutantes/metabolismo , Unión Proteica , Receptores de Lipoproteína , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Transfección
9.
J Biol Chem ; 286(22): 19735-43, 2011 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-21478160

RESUMEN

Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) is an endothelial cell protein that transports lipoprotein lipase (LPL) from the subendothelial spaces to the capillary lumen. GPIHBP1 contains two main structural motifs, an amino-terminal acidic domain enriched in aspartates and glutamates and a lymphocyte antigen 6 (Ly6) motif containing 10 cysteines. All of the cysteines in the Ly6 domain are disulfide-bonded, causing the protein to assume a three-fingered structure. The acidic domain of GPIHBP1 is known to be important for LPL binding, but the involvement of the Ly6 domain in LPL binding requires further study. To assess the importance of the Ly6 domain, we created a series of GPIHBP1 mutants in which each residue of the Ly6 domain was changed to alanine. The mutant proteins were expressed in Chinese hamster ovary (CHO) cells, and their expression level on the cell surface and their ability to bind LPL were assessed with an immunofluorescence microscopy assay and a Western blot assay. We identified 12 amino acids within GPIHBP1, aside from the conserved cysteines, that are important for LPL binding; nine of those were clustered in finger 2 of the GPIHBP1 three-fingered motif. The defective GPIHBP1 proteins also lacked the ability to transport LPL from the basolateral to the apical surface of endothelial cells. Our studies demonstrate that the Ly6 domain of GPIHBP1 is important for the ability of GPIHBP1 to bind and transport LPL.


Asunto(s)
Proteínas Portadoras/metabolismo , Células Endoteliales/metabolismo , Lipoproteína Lipasa/metabolismo , Sustitución de Aminoácidos , Animales , Células CHO , Proteínas Portadoras/genética , Cricetinae , Cricetulus , Humanos , Lipoproteína Lipasa/genética , Mutación Missense , Mapeo Peptídico/métodos , Estructura Terciaria de Proteína , Transporte de Proteínas/fisiología , Receptores de Lipoproteína
10.
Arterioscler Thromb Vasc Biol ; 31(1): 176-82, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20966398

RESUMEN

OBJECTIVE: To define the ability of GPIHBP1 to bind other lipase family members and other apolipoproteins (apos) and lipoproteins. METHODS AND RESULTS: GPIHBP1, a GPI-anchored lymphocyte antigen (Ly)6 protein of capillary endothelial cells, binds lipoprotein lipase (LPL) avidly, but its ability to bind related lipase family members has never been evaluated. As judged by cell-based and cell-free binding assays, LPL binds to GPIHBP1, but other members of the lipase family do not. We also examined the binding of apoAV-phospholipid disks to GPIHBP1. ApoAV binds avidly to GPIHBP1-transfected cells; this binding requires GPIHBP1's amino-terminal acidic domain and is independent of its cysteine-rich Ly6 domain (the latter domain is essential for LPL binding). GPIHBP1-transfected cells did not bind high-density lipoprotein. Chylomicrons bind avidly to GPIHBP1-transfected Chinese hamster ovary cells, but this binding is dependent on GPIHBP1's ability to bind LPL within the cell culture medium. CONCLUSIONS: GPIHBP1 binds LPL but does not bind other lipase family members. GPIHBP1 binds apoAV but does not bind apoAI or high-density lipoprotein. The ability of GPIHBP1-transfected Chinese hamster ovary cells to bind chylomicrons is mediated by LPL; chylomicron binding does not occur unless GPIHBP1 first captures LPL from the cell culture medium.


Asunto(s)
Capilares/metabolismo , Proteínas Portadoras/metabolismo , Células Endoteliales/metabolismo , Animales , Apolipoproteínas A/metabolismo , Células CHO , Capilares/citología , Proteínas Portadoras/genética , Quilomicrones/metabolismo , Cricetinae , Cricetulus , Humanos , Lipoproteína Lipasa/metabolismo , Lipoproteínas HDL/metabolismo , Mutación , Unión Proteica , Dominios y Motivos de Interacción de Proteínas , Mapeo de Interacción de Proteínas , Receptores de Lipoproteína , Proteínas Recombinantes de Fusión/metabolismo , Transfección
11.
Arterioscler Thromb Vasc Biol ; 30(11): 2106-13, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20814015

RESUMEN

OBJECTIVE: To determine whether plasma triglyceride levels in adult Glycosylphosphatidylinositol HDL-binding protein 1 (GPIHBP1)-deficient (Gpihbp1(-/-)) mice would be sensitive to cholesterol intake. METHODS AND RESULTS: Gpihbp1(-/-) mice were fed a Western diet containing 0.15% cholesterol. After 4 to 8 weeks, their plasma triglyceride levels were 113 to 135 mmol/L. When 0.005% ezetimibe was added to the diet to block cholesterol absorption, Lpl expression in the liver was reduced significantly, and the plasma triglyceride levels were significantly higher (>170 mmol/L). We also assessed plasma triglyceride levels in Gpihbp1(-/-) mice fed Western diets containing either high (1.3%) or low (0.05%) amounts of cholesterol. The high-cholesterol diet significantly increased Lpl expression in the liver and lowered plasma triglyceride levels. CONCLUSIONS: Treatment of Gpihbp1(-/-) mice with ezetimibe lowers Lpl expression in the liver and increases plasma triglyceride levels. A high-cholesterol diet had the opposite effects. Thus, cholesterol intake modulates plasma triglyceride levels in Gpihbp1(-/-) mice.


Asunto(s)
Anticolesterolemiantes/farmacología , Azetidinas/farmacología , Colesterol/metabolismo , Grasas de la Dieta/metabolismo , Receptores de Lipoproteína/deficiencia , Triglicéridos/metabolismo , Animales , Modelos Animales de Enfermedad , Ezetimiba , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratones , Triglicéridos/sangre
12.
Cell Metab ; 12(1): 42-52, 2010 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-20620994

RESUMEN

The lipolytic processing of triglyceride-rich lipoproteins by lipoprotein lipase (LPL) is the central event in plasma lipid metabolism, providing lipids for storage in adipose tissue and fuel for vital organs such as the heart. LPL is synthesized and secreted by myocytes and adipocytes, but then finds its way into the lumen of capillaries, where it hydrolyzes lipoprotein triglycerides. The mechanism by which LPL reaches the lumen of capillaries has remained an unresolved problem of plasma lipid metabolism. Here, we show that GPIHBP1 is responsible for the transport of LPL into capillaries. In Gpihbp1-deficient mice, LPL is mislocalized to the interstitial spaces surrounding myocytes and adipocytes. Also, we show that GPIHBP1 is located at the basolateral surface of capillary endothelial cells and actively transports LPL across endothelial cells. Our experiments define the function of GPIHBP1 in triglyceride metabolism and provide a mechanism for the transport of LPL into capillaries.


Asunto(s)
Capilares/enzimología , Lipoproteína Lipasa/metabolismo , Receptores de Lipoproteína/metabolismo , Tejido Adiposo/irrigación sanguínea , Animales , Células Endoteliales/enzimología , Células Endoteliales/metabolismo , Metabolismo de los Lípidos , Lipoproteína Lipasa/análisis , Lipoproteínas/metabolismo , Ratones , Ratones Noqueados , Receptores de Lipoproteína/análisis , Receptores de Lipoproteína/genética , Triglicéridos/metabolismo
13.
J Lipid Res ; 51(6): 1535-45, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20026666

RESUMEN

We investigated a family from northern Sweden in which three of four siblings have congenital chylomicronemia. LPL activity and mass in pre- and postheparin plasma were low, and LPL release into plasma after heparin injection was delayed. LPL activity and mass in adipose tissue biopsies appeared normal. [(35)S]Methionine incorporation studies on adipose tissue showed that newly synthesized LPL was normal in size and normally glycosylated. Breast milk from the affected female subjects contained normal to elevated LPL mass and activity levels. The milk had a lower than normal milk lipid content, and the fatty acid composition was compatible with the milk lipids being derived from de novo lipogenesis, rather than from the plasma lipoproteins. Given the delayed release of LPL into the plasma after heparin, we suspected that the chylomicronemia might be caused by mutations in GPIHBP1. Indeed, all three affected siblings were compound heterozygotes for missense mutations involving highly conserved cysteines in the Ly6 domain of GPIHBP1 (C65S and C68G). The mutant GPIHBP1 proteins reached the surface of transfected Chinese hamster ovary cells but were defective in their ability to bind LPL (as judged by both cell-based and cell-free LPL binding assays). Thus, the conserved cysteines in the Ly6 domain are crucial for GPIHBP1 function.


Asunto(s)
Proteínas Portadoras/química , Proteínas Portadoras/genética , Quilomicrones/metabolismo , Secuencia Conservada , Cisteína , Trastornos del Metabolismo de los Lípidos/genética , Mutación , Tejido Adiposo/enzimología , Tejido Adiposo/patología , Adolescente , Adulto , Alelos , Animales , Apolipoproteína C-II/deficiencia , Secuencia de Bases , Células CHO , Proteínas Portadoras/metabolismo , Preescolar , Cricetinae , Cricetulus , Femenino , Regulación de la Expresión Génica , Heparina/administración & dosificación , Heparina/farmacología , Heterocigoto , Humanos , Trastornos del Metabolismo de los Lípidos/enzimología , Trastornos del Metabolismo de los Lípidos/metabolismo , Trastornos del Metabolismo de los Lípidos/patología , Lipoproteína Lipasa/sangre , Lipoproteína Lipasa/genética , Lipoproteína Lipasa/metabolismo , Masculino , Persona de Mediana Edad , Leche Humana/enzimología , Mutación Missense , Estructura Terciaria de Proteína , Receptores de Lipoproteína , Hermanos , Transfección
14.
J Biol Chem ; 284(44): 30240-7, 2009 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-19726683

RESUMEN

GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, binds lipoprotein lipase (LPL) avidly and is required for the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 contains two key structural motifs, an acidic domain and an Ly6 motif (a three-fingered domain specified by 10 cysteines). The acidic domain is required for LPL binding, but the importance of the Ly6 domain is less clear. To explore that issue, we transfected cells with a wild-type GPIHBP1 expression vector or mutant GPIHBP1 vectors in which specific cysteines in the Ly6 domain were changed to alanine. The mutant GPIHBP1 proteins reached the cell surface, as judged by antibody binding studies and by the ability of a phosphatidylinositol-specific phospholipase C to release these proteins from the cell surface. However, cells expressing the cysteine mutants could not bind LPL. The acidic domain of the cysteine mutants appeared to remain accessible, as judged by binding studies with an antibody against the acidic domain. We also developed a cell-free assay of LPL binding. We created a rat monoclonal antibody against the carboxyl terminus of mouse GPIHBP1 and used that antibody to coat agarose beads. We then tested the ability of soluble forms of GPIHBP1 that had been immobilized on monoclonal antibody-coated beads to bind LPL. In this assay, wild-type soluble GPIHBP1 bound LPL avidly, but the cysteine mutants did not. Thus, our studies suggest that a structurally intact Ly6 domain (in addition to the acidic domain) is essential for LPL binding.


Asunto(s)
Cisteína , Lipoproteína Lipasa/metabolismo , Receptores de Lipoproteína/metabolismo , Sustitución de Aminoácidos , Animales , Antígenos Ly/metabolismo , Sitios de Unión , Secuencia Conservada , Cisteína/genética , Ratones , Mutagénesis Sitio-Dirigida , Unión Proteica , Receptores de Lipoproteína/química , Receptores de Lipoproteína/genética
15.
Curr Opin Lipidol ; 20(3): 211-6, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19369870

RESUMEN

PURPOSE OF REVIEW: This review will provide an update on the structure of GPIHBP1, a 28-kDa glycosylphosphatidylinositol-anchored glycoprotein, and its role in the lipolytic processing of triglyceride-rich lipoproteins. RECENT FINDINGS: Gpihbp1 knockout mice on a chow diet have milky plasma and plasma triglyceride levels of more than 3000 mg/dl. GPIHBP1 is located on the luminal surface of endothelial cells in tissues where lipolysis occurs: heart, skeletal muscle, and adipose tissue. The pattern of lipoprotein lipase (LPL) release into the plasma after an intravenous injection of heparin is abnormal in Gpihbp1-deficient mice, suggesting that GPIHBP1 plays a direct role in binding LPL within the tissues of mice. Transfection of CHO cells with a GPIHBP1 expression vector confers on cells the ability to bind both LPL and chylomicrons. Two regions of GPIHBP1 are required for the binding of LPL - an amino-terminal acidic domain and the cysteine-rich Ly6 domain. GPIHBP1 expression in mice changes with fasting and refeeding and is regulated in part by peroxisome proliferator-activated receptor-gamma. SUMMARY: GPIHBP1, an endothelial cell-surface glycoprotein, binds LPL and is required for the lipolytic processing of triglyceride-rich lipoproteins.


Asunto(s)
Glicoproteínas/metabolismo , Lipólisis , Animales , Regulación de la Expresión Génica , Glicoproteínas/química , Glicoproteínas/deficiencia , Glicoproteínas/genética , Humanos , Hiperlipidemias/metabolismo , Lipoproteína Lipasa/metabolismo , Estructura Terciaria de Proteína , Receptores de Lipoproteína/química , Receptores de Lipoproteína/deficiencia , Receptores de Lipoproteína/genética , Receptores de Lipoproteína/metabolismo
16.
Arterioscler Thromb Vasc Biol ; 29(6): 956-62, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19304573

RESUMEN

OBJECTIVE: GPIHBP1 is an endothelial cell protein that binds lipoprotein lipase (LPL) and chylomicrons. Because GPIHBP1 deficiency causes chylomicronemia in mice, we sought to determine whether some cases of chylomicronemia in humans could be attributable to defective GPIHBP1 proteins. METHODS AND RESULTS: Patients with severe hypertriglyceridemia (n=60, with plasma triglycerides above the 95th percentile for age and gender) were screened for mutations in GPIHBP1. A homozygous GPIHBP1 mutation (c.344A>C) that changed a highly conserved glutamine at residue 115 to a proline (p.Q115P) was identified in a 33-year-old male with lifelong chylomicronemia. The patient had failure-to-thrive as a child but had no history of pancreatitis. He had no mutations in LPL, APOA5, or APOC2. The Q115P substitution did not affect the ability of GPIHBP1 to reach the cell surface. However, unlike wild-type GPIHBP1, GPIHBP1-Q115P lacked the ability to bind LPL or chylomicrons (d < 1.006 g/mL lipoproteins from Gpihbp1(-/-) mice). Mouse GPIHBP1 with the corresponding mutation (Q114P) also could not bind LPL. CONCLUSIONS: A homozygous missense mutation in GPIHBP1 (Q115P) was identified in a patient with chylomicronemia. The mutation eliminated the ability of GPIHBP1 to bind LPL and chylomicrons, strongly suggesting that it caused the patient's chylomicronemia.


Asunto(s)
Proteínas Portadoras/genética , Quilomicrones/genética , Hiperlipoproteinemia Tipo I/genética , Hipertrigliceridemia/genética , Lipoproteína Lipasa/metabolismo , Mutación Missense , Adulto , Animales , Células CHO , Proteínas Portadoras/metabolismo , Quilomicrones/metabolismo , Cricetinae , Cricetulus , Homocigoto , Humanos , Hiperlipoproteinemia Tipo I/sangre , Hiperlipoproteinemia Tipo I/enzimología , Hipertrigliceridemia/sangre , Hipertrigliceridemia/enzimología , Masculino , Ratones , Ratones Noqueados , Fenotipo , Unión Proteica , Transporte de Proteínas , Receptores de Lipoproteína/deficiencia , Receptores de Lipoproteína/genética , Índice de Severidad de la Enfermedad , Transfección
17.
Biochim Biophys Acta ; 1791(1): 69-75, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19022396

RESUMEN

Coenzyme Q is a redox active lipid essential for aerobic respiration. The Coq4 polypeptide is required for Q biosynthesis and growth on non-fermentable carbon sources, however its exact function in this pathway is not known. Here we probe the functional roles of Coq4p in a yeast Q biosynthetic polypeptide complex. A yeast coq4-1 mutant harboring an E226K substitution is unable to grow on nonfermentable carbon sources. The coq4-1 yeast mutant retains significant Coq3p O-methyltransferase activity, and mitochondria isolated from coq4-1 and coq4-2 (E(121)K) yeast point mutants contain normal steady state levels of Coq polypeptides, unlike the decreased levels of Coq polypeptides generally found in strains harboring coq gene deletions. Digitonin-solubilized mitochondrial extracts prepared from yeast coq4 point mutants show that Coq3p and Coq4 polypeptides no longer co-migrate as high molecular mass complexes by one- and two-dimensional Blue Native-PAGE. Similarly, gel filtration chromatography confirms that O-methyltransferase activity, Coq3p, Coq4p, and Coq7p migration are disorganized in the coq4-1 mutant mitochondria. The data suggest that Coq4p plays an essential role in organizing a Coq enzyme complex required for Q biosynthesis.


Asunto(s)
Proteínas Mitocondriales/fisiología , Proteínas de Saccharomyces cerevisiae/fisiología , Ubiquinona/biosíntesis , Secuencia de Aminoácidos , Metiltransferasas/metabolismo , Proteínas Mitocondriales/genética , Datos de Secuencia Molecular , Mutación Puntual , Saccharomyces cerevisiae/citología , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética , Alineación de Secuencia
18.
J Biol Chem ; 283(50): 34511-8, 2008 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-18845532

RESUMEN

GPIHBP1-deficient mice (Gpihbp1(-/-)) exhibit severe chylomicronemia. GPIHBP1 is located within capillaries of muscle and adipose tissue, and expression of GPIHBP1 in Chinese hamster ovary cells confers upon those cells the ability to bind lipoprotein lipase (LPL). However, there has been absolutely no evidence that GPIHBP1 actually interacts with LPL in vivo. Heparin is known to release LPL from its in vivo binding sites, allowing it to enter the plasma. After an injection of heparin, we reasoned that LPL bound to GPIHBP1 in capillaries would be released very quickly, and we hypothesized that the kinetics of LPL entry into the plasma would differ in Gpihbp1(-/-) and control mice. Indeed, plasma LPL levels peaked very rapidly (within 1 min) after heparin in control mice. In contrast, plasma LPL levels in Gpihbp1(-/-) mice were much lower 1 min after heparin and increased slowly over 15 min. In keeping with that result, plasma triglycerides fell sharply within 10 min after heparin in wild-type mice, but were negligibly altered in the first 15 min after heparin in Gpihbp1(-/-) mice. Also, an injection of Intralipid released LPL into the plasma of wild-type mice but was ineffective in releasing LPL in Gpihbp1(-/-) mice. The observed differences in LPL release cannot be ascribed to different tissue stores of LPL, as LPL mass levels in tissues were similar in Gpihbp1(-/-) and control mice. The differences in LPL release after intravenous heparin and Intralipid strongly suggest that GPIHBP1 represents an important binding site for LPL in vivo.


Asunto(s)
Regulación Enzimológica de la Expresión Génica , Lipoproteína Lipasa/sangre , Receptores de Lipoproteína/genética , Animales , Sitios de Unión , Emulsiones Grasas Intravenosas/farmacología , Fibrinolíticos/farmacología , Heparina/farmacología , Cinética , Lipoproteína Lipasa/química , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Factores de Tiempo , Distribución Tisular , Triglicéridos/metabolismo
19.
J Biol Chem ; 283(43): 29554-62, 2008 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-18713736

RESUMEN

GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, plays a key role in the lipolysis of triglyceride-rich lipoproteins (e.g. chylomicrons). GPIHBP1 is expressed along the luminal surface of endothelial cells of heart, skeletal muscle, and adipose tissue, and GPIHBP1-expressing cells bind lipoprotein lipase (LPL) and chylomicrons avidly. GPIHBP1 contains an amino-terminal acidic domain (amino acids 24-48) that is enriched in aspartate and glutamate residues, and we previously speculated that this domain might be important in binding ligands. To explore the functional importance of the acidic domain, we tested the ability of polyaspartate or polyglutamate peptides to block the binding of ligands to pgsA-745 Chinese hamster ovary cells that overexpress GPIHBP1. Both polyaspartate and polyglutamate blocked LPL and chylomicron binding to GPIHBP1. Also, a rabbit antiserum against the acidic domain of GPIHBP1 blocked LPL and chylomicron binding to GPIHBP1-expressing cells. Replacing the acidic amino acids within GPIHBP1 residues 38-48 with alanine eliminated the ability of GPIHBP1 to bind LPL and chylomicrons. Finally, mutation of the positively charged heparin-binding domains within LPL and apolipoprotein AV abolished the ability of these proteins to bind to GPIHBP1. These studies indicate that the acidic domain of GPIHBP1 is important and that electrostatic interactions play a key role in ligand binding.


Asunto(s)
Proteínas Portadoras/química , Quilomicrones/química , Lipoproteína Lipasa/fisiología , Animales , Células CHO , Proteínas Portadoras/metabolismo , Cricetinae , Cricetulus , Humanos , Concentración de Iones de Hidrógeno , Ligandos , Lipoproteína Lipasa/química , Ratones , Péptidos/química , Ácido Poliglutámico/química , Unión Proteica , Estructura Terciaria de Proteína , Receptores de Lipoproteína
20.
J Lipid Res ; 49(6): 1312-21, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18340083

RESUMEN

GPIHBP1 is a glycosylphosphatidylinositol-anchored protein in the lymphocyte antigen 6 (Ly-6) family that recently was identified as a platform for the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 binds both LPL and chylomicrons and is expressed on the luminal face of microvascular endothelial cells. Here, we show that mouse GPIHBP1 is N-glycosylated at Asn-76 within the Ly-6 domain. Human GPIHBP1 is also glycosylated. The N-linked glycan could be released from mouse GPIHBP1 with N-glycosidase F, endoglycosidase H, or endoglycosidase F1. The glycan was marginally sensitive to endoglycosidase F2 digestion but resistant to endoglycosidase F3 digestion, suggesting that the glycan on GPIHBP1 is of the oligomannose type. Mutating the N-glycosylation site in mouse GPIHBP1 results in an accumulation of GPIHBP1 in the endoplasmic reticulum and a markedly reduced amount of the protein on the cell surface. Consistent with this finding, cells expressing a nonglycosylated GPIHBP1 lack the ability to bind LPL or chylomicrons. Eliminating the N-glycosylation site in a truncated soluble version of GPIHBP1 causes a modest reduction in the secretion of the protein. These studies demonstrate that N-glycosylation of GPIHBP1 is important for the trafficking of GPIHBP1 to the cell surface.


Asunto(s)
Asparagina/metabolismo , Quilomicrones/metabolismo , Lipoproteína Lipasa/metabolismo , Receptores de Lipoproteína/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Western Blotting , Células CHO , Membrana Celular/metabolismo , Cricetinae , Cricetulus , Cartilla de ADN , Glicosilación , Humanos , Ratones , Microscopía Fluorescente , Unión Proteica , Transporte de Proteínas , Receptores de Lipoproteína/química , Homología de Secuencia de Aminoácido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA